SHSE:603233's Forward Dividend Yield % is ranked better than 82.85% of 274
companies
in the Healthcare Providers & Services industry
Industry Median: 2.525
vs SHSE:603233: 5.10
During the past 12 months, DaShenLin Pharmaceutical Group Co's average Dividends Per Share Growth Rate was 4.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 15.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 13.30% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of DaShenLin Pharmaceutical Group Co was 27.60% per year. The lowest was 10.20% per year. And the median was 20.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
DaShenLin Pharmaceutical Group Co (SHSE:603233) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
DaShenLin Pharmaceutical Group Co Forward Dividend Yield % Related Terms
DaShenLin Pharmaceutical Group Co Forward Dividend Yield % Competitor Comparison
For the Pharmaceutical Retailers subindustry, DaShenLin Pharmaceutical Group Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaShenLin Pharmaceutical Group Co Forward Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DaShenLin Pharmaceutical Group Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where DaShenLin Pharmaceutical Group Co's Forward Dividend Yield % falls into.
DaShenLin Pharmaceutical Group Co Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
DaShenLin Pharmaceutical Group Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.490000
2026-06-26
2026-06-25
2026-06-26
Cash Dividend
semi-annually
CNY:CNY 1.000000
CNY 0.340000
2025-11-06
2025-11-05
2025-11-06
Cash Dividend
semi-annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 5.10% mean?
DaShenLin Pharmaceutical Group Co (SHSE:603233) has a Forward Dividend Yield % of 5.10% as of Jul. 04, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on DaShenLin Pharmaceutical Group Co and its competitors. According to the industry distribution chart, DaShenLin Pharmaceutical Group Co ranks #47 out of 274 companies in the Healthcare Providers & Services industry, placing it in the top 17.2%.
Is DaShenLin Pharmaceutical Group Co's Forward Dividend Yield % too high?
DaShenLin Pharmaceutical Group Co's current Forward Dividend Yield % is 5.10%. The Healthcare Providers & Services industry median Forward Dividend Yield % is 2.53. DaShenLin Pharmaceutical Group Co's value of 5.10% is 102% above this industry median. Based on the distribution chart, DaShenLin Pharmaceutical Group Co ranks #47 out of 274 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DaShenLin Pharmaceutical Group Co has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DaShenLin Pharmaceutical Group Co's Forward Dividend Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DaShenLin Pharmaceutical Group Co ranks #47 out of 274 companies for Forward Dividend Yield %. This places DaShenLin Pharmaceutical Group Co in the top 17% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 2.53. DaShenLin Pharmaceutical Group Co's value of 5.10% is 102% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.53, based on 274 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DaShenLin Pharmaceutical Group Co's current Forward Dividend Yield % of 5.10% is 102% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on DaShenLin Pharmaceutical Group Co and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DaShenLin Pharmaceutical Group Co's current Forward Dividend Yield % is 5.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaShenLin Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, DaShenLin Pharmaceutical Group Co (SHSE:603233) is currently considered Fairly Valued. The stock's GF Value™ is ¥18.73, compared to a current price of ¥17.05 — trading 9% below its estimated fair value. The current Forward Dividend Yield % is 5.10% and 102% above the Healthcare Providers & Services industry median of 2.53. DaShenLin Pharmaceutical Group Co's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For DaShenLin Pharmaceutical Group Co (SHSE:603233), the current Forward Dividend Yield % is 5.10% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DaShenLin Pharmaceutical Group Co (SHSE:603233) Overvalued in 2026?
Based on GuruFocus' analysis, DaShenLin Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥17.05 is trading 9% below its estimated GF Value™ of ¥18.73.
GuruFocus considers DaShenLin Pharmaceutical Group Co to be Fairly Valued.
Key valuation signals for SHSE:603233:
Forward Dividend Yield %: 5.10%
GF Value™: ¥18.73 vs. price of ¥17.05 (9% below fair value)
Industry Position: 102% above the Healthcare Providers & Services median (#47 of 274)
No single metric tells the full story. See the SHSE:603233 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DaShenLin Pharmaceutical Group Co Business Description
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail, and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.
95GF Score
Get the complete analysis for SHSE:603233
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603233 has been successfully added to your 